Stockreport

Coloplast A/S - Announcement no. 02/2024 - Interim Financial Report, H1 2023/24 [Yahoo! Finance]

COLOPLAST AS SP/ADR  (CLPBY) 
NASDAQ:AMEX Investor Relations: coloplast.com/investor-relations
PDF Coloplast delivered a solid Q2 with 8% organic growth and an EBIT margin of 27%. Reported revenue in DKK grew 9% with 4%-points contribution from Kerecis (underlying gr [Read more]